XML 23 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Cash receipts from customers $ 58,873.0 $ 43,369.0
Cash paid for inventory and prescriptions dispensed by retail network pharmacies (35,645.0) (35,102.0)
Insurance benefits paid (12,951.0) (1,093.0)
Cash paid to other suppliers and employees (7,403.0) (4,271.0)
Interest and investment income received 250.0 50.0
Interest Paid (1,123.0) (545.0)
Income taxes paid (53.0) (53.0)
Net cash provided by operating activities 1,948.0 2,355.0
Cash flows from investing activities:    
Proceeds from sales and maturities of investments 1,986.0 10.0
Purchase of investments (2,047.0) (33.0)
Purchases of property and equipment (716.0) (482.0)
Acquisitions (net of cash acquired) (124.0) (353.0)
Proceeds from sale of subsidiary 0.0 725.0
Other 10.0 2.0
Net cash used in investing activities (891.0) (131.0)
Cash flows from financing activities:    
Net borrowings (repayments) of short-term debt 2,285.0 (1,276.0)
Proceeds from issuance of long-term debt 0.0 39,376.0
Repayments of long-term debt (882.0) (1.0)
Derivative settlements 0.0 446.0
Dividends paid (649.0) (508.0)
Proceeds from exercise of stock options 101.0 107.0
Payments for taxes related to net share settlement of equity awards (44.0) (4.0)
Other 5.0 0.0
Net cash provided by financing activities 816.0 38,140.0
Cash and cash equivalents at the beginning of the period 4,295.0 1,900.0
Cash and cash equivalents at the end of the period 6,168.0 42,264.0
Reconciliation of net income to net cash provided by operating activities:    
Net income 1,427.0 998.0
Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]    
Depreciation and amortization 1,111.0 644.0
Stock-based compensation 114.0 55.0
Deferred income taxes and other noncash items 153.0 62.0
Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]    
Accounts receivable, net (1,989.0) (857.0)
Inventories 1,001.0 464.0
Other assets (389.0) (57.0)
Accounts payable and pharmacy claims and discounts payable (22.0) (178.0)
Health care costs payable and other insurance liabilities 553.0 236.0
Other liabilities (11.0) 988.0
Net cash provided by operating activities 1,948.0 2,355.0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease) $ 1,873.0 $ 40,364.0